$227.09
+0.59%
N/A+$1.34
Healthcare
Medical - Distribution
NYSE
Active Trading
Cardinal Health, Inc. operates as a global, integrated provider of healthcare services and products, with its reach spanning the United States, Canada, ...
C-Suite Executives
(0)The C-suite executives form a cohesive leadership team driving the company's financial strategy and innovation.
Key Team Members
No executives available for this level
Founder / CEO
3
C-Level
6
VP
0
Board
0
Director / Board
1
Other
0
Key Executives
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
| Jason Hollar | Chief Executive Officer & Director | USD 5,544,754 | 1973 | Active | |
| Aaron E. Alt | Chief Financial Officer | USD 2,232,222 | 1972 | Active | |
| Deborah L. Weitzman | Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment | USD 1,736,640 | 1965 | Active | |
| Jessica L. Mayer | Chief Legal & Compliance Officer | USD 1,722,409 | 1969 | Active | |
| Stephen Mason | Chief Executive Officer of GMPD segment | USD 1,387,127 | 1971 | Active | |
| Patricia English | Senior Vice President | USD 451,344 | 1980 | Active | |
| Craig Cowman | President of Biopharma Solutions & Strategic Sourcing | — | — | Active | |
| Matt Sims | Vice President of Investor Relations | — | — | — | Active |
| Mary C. Scherer | Senior Vice President & Chief Accounting Officer | — | — | Active | |
| Valerie Christine Pitteroff | Chief Human Resources Officer | — | — | Active |
Executive Compensation
(deduped by latest filing date per person-year)| Filing Date | Year | Name | Position | Level | Salary | Bonus | Stock Award | Option Award | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-16 | 2025 | Jason M. Hollar | Chief Chief Executive Officer | Founder / CEO | $1.49M | $0 | $13.43M | $0 | $3.55M | $500.68K | $18.98M |
| 2025-09-16 | 2025 | Aaron E. Alt | Chief Chief Financial Officer | C-Level | $871.16K | $0 | $3.98M | $0 | $1.30M | $57.80K | $6.21M |
| 2025-09-16 | 2025 | Deborah L. Weitzman | Chief Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment | Founder / CEO | $741.93K | $0 | $3.77M | $0 | $964.51K | $30.20K | $5.51M |
| 2025-09-16 | 2025 | Jessica L. Mayer | Chief Chief Legal and Compliance Officer | C-Level | $716.93K | $0 | $3.20M | $0 | $975.03K | $30.45K | $4.93M |
| 2025-09-16 | 2025 | Stephen M. Mason | Chief Chief Executive Officer, Global Medical Products and Distribution Segment | Founder / CEO | $741.93K | $0 | $3.36M | $0 | $593.54K | $51.65K | $4.75M |
| 2025-09-16 | 2024 | Jason M. Hollar | Chief Chief Executive Officer | Founder / CEO | $1.43M | $0 | $20.64M | $0 | $3.11M | $464.03K | $25.65M |
| 2025-09-16 | 2024 | Stephen M. Mason | Chief Chief Executive Officer, Global Medical Products and Distribution Segment | Founder / CEO | $721.04K | $0 | $5.97M | $0 | $627.30K | $16.15K | $7.34M |
| 2025-09-16 | 2024 | Aaron E. Alt | Chief Chief Financial Officer | C-Level | $846.04K | $0 | $4.82M | $0 | $1.15M | $18.75K | $6.84M |
| 2025-09-16 | 2024 | Deborah L. Weitzman | Chief Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment | Founder / CEO | $709.15K | $0 | $3.60M | $0 | $758.79K | $21.92K | $5.09M |
| 2025-09-16 | 2024 | Jessica L. Mayer | Chief Chief Legal and Compliance Officer | C-Level | $696.04K | $0 | $3.08M | $0 | $863.09K | $13.80K | $4.66M |
| 2025-09-16 | 2023 | Jason M. Hollar | Chief Chief Executive Officer | Founder / CEO | $1.25M | $0 | $14.83M | $0 | $2.38M | $328.29K | $18.79M |
| 2025-09-16 | 2023 | Aaron E. Alt | Chief Chief Financial Officer | C-Level | $375.20K | $1.00M | $3.82M | $0 | $544.80K | $265.01K | $6.00M |
| 2023-09-27 | 2023 | Victor L. Crawford | Former Former Chief Chief Executive Officer, Pharmaceutical Segment | Founder / CEO | $280.67K | $0 | $3.18M | $0 | $0 | $1.30M | $4.77M |
| 2025-09-16 | 2023 | Stephen M. Mason | Chief Chief Executive Officer, Global Medical Products and Distribution Segment | Founder / CEO | $695.96K | $0 | $3.18M | $0 | $521.97K | $20.73K | $4.42M |
| 2025-09-16 | 2023 | Jessica L. Mayer | Chief Chief Legal and Compliance Officer | C-Level | $666.92K | $0 | $2.92M | $0 | $800.30K | $13.81K | $4.40M |
| 2025-09-16 | 2023 | Deborah L. Weitzman | Chief Chief Executive Officer, Pharmaceutical and Specialty Solutions Segment | Founder / CEO | $606.14K | $0 | $2.67M | $0 | $773.98K | $19.02K | $4.07M |
| 2023-09-27 | 2023 | Michael C. Kaufmann | Former Former Chief Chief Executive Officer | Founder / CEO | $233.01K | $0 | $0 | $0 | $0 | $3.30M | $3.53M |
| 2023-09-27 | 2023 | Patricia M. English | Former Former Interim Chief Chief Financial Officer | C-Level | $291.46K | $0 | $811.40K | $0 | $146.71K | $13.17K | $1.26M |
| 2023-09-27 | 2022 | Michael C. Kaufmann | Former Former Chief Chief Executive Officer | Founder / CEO | $1.34M | $0 | $11.05M | $0 | $805.07K | $265.64K | $13.46M |
| 2024-09-16 | 2022 | Jessica L. Mayer | Chief Chief Legal and Compliance Officer | C-Level | $616.78K | $0 | $4.26M | $0 | $244.25K | $12.43K | $5.14M |
| 2024-09-16 | 2022 | Jason M. Hollar | Chief Chief Executive Officer | Founder / CEO | $729.25K | $0 | $2.76M | $0 | $320.87K | $69.79K | $3.88M |
| 2023-09-27 | 2022 | Victor L. Crawford | Former Former Chief Chief Executive Officer, Pharmaceutical Segment | Founder / CEO | $741.29K | $0 | $2.76M | $0 | $296.52K | $12.20K | $3.81M |
| 2024-09-16 | 2022 | Stephen M. Mason | Chief Chief Executive Officer, Global Medical Products and Distribution Segment | Founder / CEO | $666.78K | $0 | $2.76M | $0 | $166.69K | $15.40K | $3.61M |
| 2023-09-27 | 2021 | Michael C. Kaufmann | Former Former Chief Chief Executive Officer | Founder / CEO | $1.30M | $0 | $10.20M | $0 | $780.00K | $204.55K | $12.48M |
| 2023-09-27 | 2021 | Victor L. Crawford | Former Former Chief Chief Executive Officer, Pharmaceutical Segment | Founder / CEO | $725.00K | $0 | $2.80M | $0 | $652.50K | $35.89K | $4.22M |
| 2023-09-27 | 2021 | Jason M. Hollar | Chief Chief Executive Officer and Former Former Chief Chief Financial Officer | Founder / CEO | $700.00K | $0 | $2.55M | $0 | $630.00K | $71.42K | $3.95M |
| 2023-09-27 | 2021 | Stephen M. Mason | Chief Chief Executive Officer, Medical Segment | Founder / CEO | $625.00K | $0 | $2.55M | $0 | $562.50K | $17.26K | $3.75M |
| 2023-09-27 | 2021 | Jessica L. Mayer | Chief Chief Legal and Compliance Officer | C-Level | $575.00K | $0 | $1.89M | $0 | $465.75K | $11.81K | $2.94M |
| 2022-09-28 | 2020 | Michael C. Kaufmann | Chief Chief Executive Officer | Founder / CEO | $1.29M | $0 | $10.24M | $0 | $2.55M | $143.03K | $14.22M |
| 2022-09-28 | 2020 | Victor L. Crawford | Chief Chief Executive Officer — Pharmaceutical Segment | Founder / CEO | $721.65K | $0 | $2.82M | $0 | $909.28K | $14.25K | $4.46M |
| 2022-09-28 | 2020 | Jason M. Hollar | Chief Chief Financial Officer | C-Level | $124.32K | $1.55M | $2.07M | $0 | $149.18K | $213.14K | $4.10M |
| 2022-09-28 | 2020 | Stephen M. Mason | Chief Chief Executive Officer — Medical Segment | Founder / CEO | $511.75K | $0 | $2.30M | $0 | $586.35K | $21.35K | $3.42M |
| 2022-09-28 | 2020 | Jessica L. Mayer | Chief Chief Legal and Compliance Officer | C-Level | $547.27K | $0 | $1.79M | $0 | $559.06K | $15.86K | $2.91M |
| 2020-09-23 | 2020 | David C. Evans | Former Former interim Chief Chief Financial Officer | C-Level | $2.18M | $0 | $0 | $0 | $0 | $26.85K | $2.21M |
| 2020-09-23 | 2020 | Jorge M. Gomez | Former Former Chief Chief Financial Officer | C-Level | $65.57K | $0 | $0 | $0 | $0 | $2.95K | $68.53K |
| 2021-09-23 | 2019 | Michael C. Kaufmann | Chief Chief Executive Officer | Founder / CEO | $1.19M | $0 | $12.11M | $0 | $2.13M | $140.58K | $15.57M |
| 2021-09-23 | 2019 | Victor L. Crawford | Chief Chief Executive Officer — Pharmaceutical Segment | Founder / CEO | $443.01K | $2.50M | $3.10M | $0 | $502.38K | $184.66K | $6.73M |
| 2019-09-20 | 2019 | Jon L. Giacomin | Former Former Chief Chief Executive Officer — Medical Segment | Founder / CEO | $805.30K | $0 | $3.04M | $0 | $0 | $26.36K | $3.87M |
| 2019-09-20 | 2019 | Craig S. Morford | Former Former Chief Chief Legal and Compliance Officer | C-Level | $463.86K | $0 | $2.28M | $0 | $425.83K | $19.49K | $3.19M |
| 2020-09-23 | 2019 | Jorge M. Gomez | Former Former Chief Chief Financial Officer | C-Level | $593.29K | $0 | $2.53M | $0 | $0 | $26.76K | $3.15M |
| 2021-09-23 | 2019 | Jessica L. Mayer | Chief Chief Legal and Compliance Officer | C-Level | $429.86K | $0 | $2.15M | $0 | $364.93K | $19.71K | $2.97M |
| 2020-09-23 | 2018 | Michael C. Kaufmann | Chief Chief Executive Officer | Founder / CEO | $955.70K | $0 | $4.90M | $948.69K | $1.52M | $100.40K | $8.42M |
| 2019-09-20 | 2018 | Jon L. Giacomin | Former Former Chief Chief Executive Officer — Medical Segment | Founder / CEO | $697.05K | $0 | $2.90M | $948.69K | $853.20K | $36.13K | $5.44M |
| 2019-09-20 | 2018 | Craig S. Morford | Former Former Chief Chief Legal and Compliance Officer | C-Level | $585.21K | $0 | $1.11M | $593.34K | $608.85K | $31.51K | $2.93M |
| 2020-09-23 | 2018 | Jorge M. Gomez | Former Former Chief Chief Financial Officer | C-Level | $478.15K | $0 | $1.29M | $163.52K | $387.36K | $37.53K | $2.36M |
| 2019-09-20 | 2017 | Michael C. Kaufmann | Chief Chief Executive Officer | Founder / CEO | $746.44K | $186.61K | $1.95M | $997.43K | $0 | $14.98K | $3.89M |
| 2019-09-20 | 2017 | Jon L. Giacomin | Former Former Chief Chief Executive Officer — Medical Segment | Founder / CEO | $567.15K | $141.79K | $1.90M | $949.93K | $0 | $14.97K | $3.57M |
| 2019-09-20 | 2017 | Craig S. Morford | Former Former Chief Chief Legal and Compliance Officer | C-Level | $552.15K | $117.33K | $1.03M | $516.63K | $0 | $14.97K | $2.23M |
Total Compensation Trend
Sum of disclosed compensation by year (USD million)
Key Roles Compensation Lines
Top founder/C-level executives over time (USD million)